Brain Behavior and Immunity, Год журнала: 2024, Номер 119, С. 709 - 712
Опубликована: Апрель 24, 2024
Язык: Английский
Brain Behavior and Immunity, Год журнала: 2024, Номер 119, С. 709 - 712
Опубликована: Апрель 24, 2024
Язык: Английский
Psychological Medicine, Год журнала: 2024, Номер unknown, С. 1 - 11
Опубликована: Окт. 2, 2024
Abstract Background While inflammation is associated with cognitive impairment in severe mental illnesses (SMI), there substantial heterogeneity and evidence of transdiagnostic subgroups across schizophrenia (SZ) bipolar (BD) spectrum disorders. There however, limited knowledge about the longitudinal course this relationship. Methods Systemic (C-Reactive Protein, CRP) cognition (nine domains) was measured from baseline to 1 year follow-up first treatment SZ BD ( n = 221), healthy controls (HC, 220). Linear mixed models were used evaluate changes separately CRP domains specific diagnostic status (SZ, BD, HC). Hierarchical clustering applied on entire sample investigate inflammatory-cognitive subgroups. Results no case-control differences or change follow-up. We confirm previous observations at both time-points domain stability/improvement over time regardless status. identified differing demographics clinical severity. Despite improvement cognition, symptoms functioning, higher – lower subgroup (75% SZ; 48% BD; 38% HC) had sustained more symptoms, functioning (SMI only) This comparison a (25% SZ, 52% 62% HC), where SMI participants showed HC level positive course. Conclusions Our findings support heterogenous that are stable time, may benefit targeted interventions.
Язык: Английский
Процитировано
2Journal of Affective Disorders, Год журнала: 2024, Номер 366, С. 217 - 225
Опубликована: Авг. 27, 2024
Язык: Английский
Процитировано
1medRxiv (Cold Spring Harbor Laboratory), Год журнала: 2023, Номер unknown
Опубликована: Ноя. 3, 2023
Abstract Recent findings link cognitive impairment and inflammatory-immune dysregulation in schizophrenia (SZ) bipolar (BD) spectrum disorders. However, heterogeneity translation between the periphery central (blood-to-brain) mechanisms remains a challenge. Starting with large SZ, BD healthy control cohort ( n =1235), we aimed to i) identify candidate peripheral markers =25) associated domains =9) elucidate heterogenous immune-cognitive patterns, ii) evaluate regulation of using human induced pluripotent stem cell (iPSC)-derived astrocytes neural progenitor cells =10), iii) marker messenger RNA expression leukocytes microarray available data from subsample main =776), RNA-sequencing deconvolution analysis postmortem brain samples =474) CommonMind Consortium (CMC). We identified transdiagnostic subgroups based on covariance (measures speed verbal learning) reflecting inflammatory response (CRP, sTNFR1, YKL-40), innate immune activation (MIF) extracellular matrix remodelling (YKL-40, CatS). Of there was considerable variance secretion YKL-40 iPSC-derived SZ compared HC. Further, provide evidence dysregulated genes encoding related signalling pathways high subgroup consisting predominantly samples. Our suggest relationship activity impairment, highlight as potential functioning individuals severe mental illness.
Язык: Английский
Процитировано
1medRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown
Опубликована: Апрель 9, 2024
Abstract Background While inflammation is associated with cognitive impairment in severe mental illnesses (SMI), there substantial heterogeneity and evidence of transdiagnostic subgroups across schizophrenia (SZ) bipolar (BD) spectrum disorders. There however, limited knowledge about the longitudinal course this relationship. Methods Systemic (C-Reactive Protein, CRP) cognition (nine domains) was measured from baseline to 1 year follow-up first treatment SZ BD (n=221), healthy controls (HC, n=220). Linear mixed models were used evaluate changes separately CRP domains specific diagnostic status (SZ, BD, HC). Hierarchical clustering applied on entire sample investigate inflammatory-cognitive subgroups. Results no case-control differences or change follow-up. We confirm previous observations at both time-points domain stability/improvement over time regardless status. identified differing demographics clinical severity. Despite improvement cognition, symptoms functioning, higher – lower subgroup (75% SZ; 48% BD; 38% HC) had sustained more symptoms, functioning (SMI only) This comparison a (25% SZ, 52% 62% HC), where SMI participants showed HC level positive course. Conclusions Our findings support heterogenous that are stable time, may benefit targeted interventions.
Язык: Английский
Процитировано
0Brain Behavior and Immunity, Год журнала: 2024, Номер 119, С. 709 - 712
Опубликована: Апрель 24, 2024
Язык: Английский
Процитировано
0